REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Biont, A.S. (Slovakia)

Main Activities: Ambulatory Health Care Services | Offices of Physicians
Full name: Biont, A.S. Profile Updated: September 09, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Biont (Slovakia) specializes in nuclear medicine, focusing on Positron Emission Tomography (PET) and operates a PET center for diagnostic examinations using radiopharmaceuticals. Biont (Slovakia)'s main activities include producing and distributing radiopharmaceuticals for PET centers, providing PET/CT and SPECT-CT examinations for patients, and manufacturing its own product, biontFDG radiopharmaceutical. Additionally, the company serves as a contract manufacturer of FDG for other companies.

Headquarters
Karloveska, 63
Bratislava; Bratislavsky; Postal Code: 84229

Contact Details: Purchase the Biont, A.S. report to view the information.

Website: http://www.biont.sk

Basic Information
Total Employees:
Purchase the Biont, A.S. report to view the information.
Registered Capital:
Purchase the Biont, A.S. report to view the information.
Financial Auditors:
Purchase the Biont, A.S. report to view the information.
Incorporation Date:
January 21, 2005
Key Executives
Purchase this report to view the information.
Chairman of the Board
Purchase this report to view the information.
Vice-chair of the Board
Purchase this report to view the information.
Member of the Board
Purchase this report to view the information.
Member of the Board
Purchase this report to view the information.
Member of the Supervisory Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Biont, A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
9.95%▲
Total operating revenue
9.71%▲
Operating profit (EBIT)
34.14%▲
EBITDA
9.32%▲
Net Profit (Loss) for the Period
2.86%▲
Total assets
30.11%▲
Total equity
31.61%▲
Operating Profit Margin (ROS)
1.58%▲
Net Profit Margin
-0.38%▼
Return on Equity (ROE)
-1.1%▼
Debt to Equity Ratio
-4.21%▼
Quick Ratio
0.7%▲
Cash Ratio
0.75%▲

Similar companies

Unilabs Slovensko, S. R. O.
 
Medirex, A.S.
Fmc - Dialyzacne Sluzby, S.R.O.
 
Slovenske Liecebne Kupele Piestany, A.S.
Procare, A.S.
 
Slovenske Liecebne Kupele Rajecke Teplice, A.S.
Kupele Lucky A.S.
 
Medicyt, A. S.
Vesely Ocna Klinika, S.R.O.
 
Kupele Nimnica, A.S.
Wesper, A.S.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo